ONCO
Price:
$0.6649
Market Cap:
$2.28M
Onconetix, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cinci...[Read more]
Industry
Biotechnology
IPO Date
2022-02-18
Stock Exchange
NASDAQ
Ticker
ONCO
According to Onconetix, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -2893719.00. This represents a change of -106.28% compared to the average of 46.10M of the last 4 quarters.
The mean historical Enterprise Value of Onconetix, Inc. over the last ten years is 4.80B. The current -2893719.00 Enterprise Value has changed -106.03% with respect to the historical average. Over the past ten years (40 quarters), ONCO's Enterprise Value was at its highest in in the December 2021 quarter at 11.09B. The Enterprise Value was at its lowest in in the March 2021 quarter at 0.
Average
4.80B
Median
210.46M
Minimum
20.43M
Maximum
11.09B
Discovering the peaks and valleys of Onconetix, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0.02%
Maximum Annual Enterprise Value = 11.09B
Minimum Annual Increase = -98.10%
Minimum Annual Enterprise Value = 20.43M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 20.43M | -47.72% |
| 2024 | 39.07M | -39.53% |
| 2023 | 64.61M | -69.30% |
| 2022 | 210.46M | -98.10% |
| 2021 | 11.09B | 0.02% |
| 2020 | 11.09B | 0.02% |
The current Enterprise Value of Onconetix, Inc. (ONCO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
41.37M
5-year avg
2.29B
10-year avg
4.80B
Onconetix, Inc.’s Enterprise Value is greater than Jasper Therapeutics, Inc. (-12225091.00), less than Azitra, Inc. (1.36M), greater than Revelation Biosciences, Inc. (-5746124.00), less than Scinai Immunotherapeutics Ltd. (1.51M), less than SciSparc Ltd. (1.38M), greater than Indaptus Therapeutics, Inc. (-3228309.00), less than Enveric Biosciences, Inc. (-2367055.00), greater than Silexion Therapeutics Ltd. (-5180812.00), less than Protagenic Therapeutics, Inc. (2.54M), greater than Salarius Pharmaceuticals, Inc. (-7720277.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -12225091.00 | $15.23M | |
| 1.36M | $2.81M | |
| -5746124.00 | $4.21M | |
| 1.51M | $906.68K | |
| 1.38M | $495.10K | |
| -3228309.00 | $5.28M | |
| -2367055.00 | $2.31M | |
| -5180812.00 | $342.19K | |
| 2.54M | $1.59M | |
| -7720277.00 | $4.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Onconetix, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Onconetix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Onconetix, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Onconetix, Inc. (ONCO)?
What is the 3-year average Enterprise Value for Onconetix, Inc. (ONCO)?
What is the 5-year average Enterprise Value for Onconetix, Inc. (ONCO)?
How does the current Enterprise Value for Onconetix, Inc. (ONCO) compare to its historical average?